Sign in

Ovarian cancer trials, also abroad

803 open Ovarian cancer trials worldwide. Travel and costs are your own unless the study pays them; ask the study team first.

CountryOpen trials
United States351
Italy101
France99
Spain90
South Korea65
All other countries

The same trial often runs in several countries

Torvutatug Samrotecan Plus Bevacizumab as First-line Maintenance in Non-Homologous Recombination Deficiency (Non-HRD) Positive Advanced Epithelial Ovarian Cancer has 32 sites in China and runs in 29 countries. If a site near you is full, another one may still take people.

See Torvutatug Samrotecan Plus Bevacizumab as First-line Maintenance in Non-Homologous Recombination Deficiency (Non-HRD) Positive Advanced Epithelial Ovarian Cancer in all 29 countries